IDX/KLBF (IDX/KLBF)

Indonesia Stock Exchange: IDX/KLBF · IDR

IDR 735

+24.99 (+3.5%)· Recorded snapshot

Market cap	33.3T
Revenue (ttm)	37.7T
Net income (ttm)	3.6T
EPS (ttm)	IDR 79.6
Shares out	45.2B
P/E (trailing)	9.2x
P/E (forward)	8.9x
Dividend	IDR 20.0 (2.72%)
Volume	52,852,600
Beta	-0.05

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 37.7T
Net income (ttm): 3.6T
EPS (ttm): IDR 79.6
P/E (trailing): 9.2x
P/E (forward): 8.9x
Market cap: 33.3T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E8.9

P25 n/aP50 n/aP75 n/a

Trailing P/E9.2

P25 n/aP50 n/aP75 n/a

ROE14.8

P25 n/aP50 n/aP75 n/a

ROIC16.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All IDX/KLBF indicators

Market & fundamental data

Available fields

261

Groups with data

Currency

IDR

Showing 261 of 261 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	IDR
Country	Indonesia
Country code	ID
Earnings date	2026-10-29
Employees	12,806
Employees change	-35
Employees growth	-0.27%
Enterprise value	IDR 30.5T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1966
Industry	Drug Manufacturers - General
Is primary listing	Yes
ISIN number	ID1000125107
Last earnings date	2025-10-30
Last refreshed	2026-10-28
Last stock split date	2012-10-08
Last stock split type	Forward
Market cap	IDR 33.3T
Next earnings date	2026-10-29
Price	IDR 735.00
Price currency	IDR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	idx/KLBF
Website	https://www.kalbe.co.id

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	9.24x
Average P/E ratio (10Y)	25.25x
Average P/E ratio (3Y)	19.48x
Average P/E ratio (5Y)	21.87x
Earnings yield	10.82%
EV/Earnings	8.46x
EV/EBIT	6.5x
EV/EBITDA	5.93x
EV/FCF	12.76x
EV/Sales	0.81x
FCF / EV yield	7.84%
FCF yield	7.2%
Forward P/E	8.94x
Graham number	981.05514
Graham upside	33.48%
Lynch fair value	IDR 397.79
Lynch upside	-45.88%
P/B ratio	1.29x
P/E ratio	9.24x
P/FCF ratio	13.9x
P/OCF ratio	10.32x
P/S ratio	0.88x
PEG ratio	0.79x
Price / tangible book value	1.51x
Price/EBITDA ratio	6.59x
Sector forward P/E	11.89x
Sector P/E	31.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	12.24%
EBITDA margin	13.37%
Effective tax rate	21.98%
FCF margin	6.34%
Gross margin	37.37%
Operating margin	12.24%
Pretax margin	12.53%
Profit margin	9.57%
Profit per employee	IDR 281.9M
Profitable quarters	62
Profitable years	21
Revenue per employee	IDR 2.9B
ROA	9.22%
ROA (5Y)	9.5%
ROCE	17.48%
ROE	14.77%
ROE (5Y)	14.67%
ROIC	16.72%
ROIC (5Y)	17.42%
Tax / revenue	2.76%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.8%
EPS growth (Q)	-0.44%
EPS growth (QoQ)	-13.45%
EPS growth 10Y	5.98%
EPS growth 3Y	4.13%
EPS growth 5Y	5.58%
EPS growth years	2
FCF growth	-18.27%
FCF growth (Q)	-7.29%
FCF growth (QoQ)	590.78%
FCF growth 3Y	49.26%
FCF growth 5Y	-3.86%
Gross profit growth	6.32%
Gross profit growth (Q)	6.55%
Gross profit growth 3Y	6.03%
Gross profit growth 5Y	6.65%
Net income growth	5.84%
Net income growth (Q)	-0.85%
Net income growth (QoQ)	-13.45%
Net income growth 3Y	3.3%
Net income growth 5Y	4.89%
Net income growth years	2
OCF growth	-13.21%
OCF growth (Q)	3.52%
OCF growth (QoQ)	274.87%
OCF growth 10Y	3.22%
OCF growth 3Y	29.8%
OCF growth 5Y	-1.51%
Operating income growth	8.77%
Operating income growth (Q)	9.68%
Operating income growth 3Y	3.34%
Operating income growth 5Y	4.46%
Revenue growth	13.02%
Revenue growth (Q)	18.2%
Revenue growth (QoQ)	1.26%
Revenue growth 10Y	7.26%
Revenue growth 3Y	7.65%
Revenue growth 5Y	9.58%
Revenue growth quarters	23
Revenue growth years	20

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	IDR -830.9B
Depreciation and amortization	IDR 426.3B
EBIT	IDR 4.6T
EBITDA	IDR 5T
EPS	IDR 79.56
FCF per share	IDR 52.89
Financing cash flow	IDR -1.2T
Free cash flow	IDR 2.4T
Gross profit	IDR 14.1T
Income taxes	IDR 1T
Investing cash flow	IDR -1.1T
Net borrowing	IDR 6.4B
Net cash flow	IDR 1T
Net income	IDR 3.6T
Operating income	IDR 4.6T
Revenue	IDR 37.7T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.45
Book value per share	IDR 537.67
Debt / EBITDA	0.16
Debt / equity	0.03
Debt / FCF	0.35
Goodwill	IDR 626.8B
Interest coverage	171.99
Long-term assets	IDR 12.1T
Long-term liabilities	IDR 659.5B
Net cash (debt)	IDR 4.2T
Net cash / market cap	12.5%
Net cash growth	31.22%
Net debt / EBITDA	-0.82
Net debt / equity	-0.16
Net debt / FCF	-1.74
Piotroski F-Score	5
Property, plant and equipment	IDR 8.4T
Shareholders' equity	IDR 25.8T
Tangible book value	IDR 22.1T
Tangible book value per share	IDR 487.34
Total assets	IDR 33.1T
Total cash	IDR 5T
Total debt	IDR 826.5B
Total liabilities	IDR 7.3T
WACC	3.97%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.21
Current assets	IDR 21T
Current liabilities	IDR 6.7T
Current ratio	3.15
Inventory turnover	3.17
Net working capital	IDR 10T
Quick ratio	1.78
Working capital	IDR 14.3T
Working capital turnover	2.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.91%
Dividend growth	-44.44%
Dividend growth (10Y)	0.51%
Dividend growth (3Y)	-19.26%
Dividend growth (5Y)	-10.07%
Dividend growth years	1
Dividend payment date	2026-06-24
Dividend payment years	20
Dividend payout frequency	Annual
Dividend per share	IDR 20.00
Dividend yield	2.72%
Ex-dividend date	2026-06-04
FCF payout ratio	37.82%
Last dividend	IDR 20.00
Payout ratio	25.07%
Shareholder yield	3.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-57.88%
10Y return CAGR	-6.41%
10Y total return	-48.46%
150-day SMA	IDR 798.97
15Y price change	5.76%
15Y return CAGR	2.24%
15Y total return	39.4%
1D price change	3.52%
1W price change	5.76%
1W total return	5.76%
1Y price change	-42.35%
1Y return CAGR	-40.75%
1Y total return	-40.73%
20-day SMA	IDR 735.50
200-day SMA	IDR 882.25
20Y price change	176.32%
20Y return CAGR	7.01%
20Y total return	287.66%
3M price change	2.8%
3M total return	2.8%
3Y price change	-58.12%
3Y return CAGR	-23.37%
3Y total return	-55.02%
50-day SMA	IDR 754.50
50-day SMA vs 200-day SMA	50under200
52-week high	IDR 1,345.00
52-week high date	2025-10-28
52-week low	IDR 630.00
52-week low date	2026-10-19
5Y price change	-54.06%
5Y return CAGR	-12.48%
5Y total return	-48.66%
6M price change	-16%
6M total return	-13.63%
All-time high	IDR 2,360.00
All-time high date	2023-02-10
All-time low	IDR 2.13
All-time low date	1998-09-21
Average true range (ATR)	IDR 30.77
Average volume	56.8M
Beta (1Y)	0.21
Beta (2Y)	0.45
Beta (5Y)	-0.05
Change from 52-week high	-45.35%
Change from 52-week low	16.67%
Change from all-time high	-68.86%
Change from all-time low	34,439.47%
Change from open	2.8%
Day's gap	0.7%
Dollar volume	IDR 38.8B
High price	IDR 740.00
Low price	IDR 715.00
Monthly RSI	29.85
Open price	IDR 715.00
Position in 52-week range	80%
Previous close	IDR 710.00
Price vs 150-day SMA	-8.01%
Price vs 20-day SMA	-0.07%
Price vs 200-day SMA	-16.69%
Price vs 50-day SMA	-2.58%
Relative volume	0.94
RSI	50.03
Sharpe ratio	-0.74
Sharpe ratio (3Y)	-0.66
Sharpe ratio (5Y)	-0.19
Sortino ratio	-0.95
Sortino ratio (3Y)	-0.81
Sortino ratio (5Y)	-0.11
Volume	52.9M
Weekly RSI	42.98
YTD price change	-39%
YTD total return	-37.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18B
Shares change (QoQ)	0%
Shares change (YoY)	-0.91%
Shares held by insiders	0.35%
Shares held by institutions	8.31%
Shares outstanding	45.2B

Deeper analysis on IDX/KLBF

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this IDX/KLBF report

Is a complete IDX/KLBF research report available?

No complete published report is available for idx/KLBF (IDX/KLBF) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

33.3T

Revenue (ttm)

37.7T

Net income (ttm)

3.6T

EPS (ttm)

IDR 79.6

Shares out

45.2B

P/E (trailing)

9.2x

P/E (forward)

8.9x

Dividend

IDR 20.0 (2.72%)

Volume

52,852,600

Beta

-0.05

Metric

Value

Amount currency

IDR

Country

Indonesia

Country code

Earnings date

2026-10-29

Employees

12,806

Employees change

-35

Employees growth

-0.27%

Enterprise value

IDR 30.5T

Exchange

Indonesia Stock Exchange

Financial currency

IDR

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1966

Industry

Drug Manufacturers - General

Is primary listing

Yes

ISIN number

ID1000125107

Last earnings date

2025-10-30

Last refreshed

2026-10-28

Last stock split date

2012-10-08

Last stock split type

Forward

Market cap

IDR 33.3T

Next earnings date

2026-10-29

Price

IDR 735.00

Price currency

IDR

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

idx/KLBF

Website

https://www.kalbe.co.id

Metric

Value

Adjusted P/E ratio

9.24x

Average P/E ratio (10Y)

25.25x

Average P/E ratio (3Y)

19.48x

Average P/E ratio (5Y)

21.87x

Earnings yield

10.82%

EV/Earnings

8.46x

EV/EBIT

6.5x

EV/EBITDA

5.93x

EV/FCF

12.76x

EV/Sales

0.81x

FCF / EV yield

7.84%

FCF yield

7.2%

Forward P/E

8.94x

Graham number

981.05514

Graham upside

33.48%

Lynch fair value

IDR 397.79

Lynch upside

-45.88%

P/B ratio

1.29x

P/E ratio

9.24x

P/FCF ratio

13.9x

P/OCF ratio

10.32x

P/S ratio

0.88x

PEG ratio

0.79x

Price / tangible book value

1.51x

Price/EBITDA ratio

6.59x

Sector forward P/E

11.89x

Sector P/E

31.2x

Metric

Value

EBIT margin

12.24%

EBITDA margin

13.37%

Effective tax rate

21.98%

FCF margin

6.34%

Gross margin

37.37%

Operating margin

12.24%

Pretax margin

12.53%

Profit margin

9.57%

Profit per employee

IDR 281.9M

Profitable quarters

Profitable years

Revenue per employee

IDR 2.9B

ROA

9.22%

ROA (5Y)

9.5%

ROCE

17.48%

ROE

14.77%

ROE (5Y)

14.67%

ROIC

16.72%

ROIC (5Y)

17.42%

Tax / revenue

2.76%

Metric

Value

EPS growth

6.8%

EPS growth (Q)

-0.44%

EPS growth (QoQ)

-13.45%

EPS growth 10Y

5.98%

EPS growth 3Y

4.13%

EPS growth 5Y

5.58%

EPS growth years

FCF growth

-18.27%

FCF growth (Q)

-7.29%

FCF growth (QoQ)

590.78%

FCF growth 3Y

49.26%

FCF growth 5Y

-3.86%

Gross profit growth

6.32%

Gross profit growth (Q)

6.55%

Gross profit growth 3Y

6.03%

Gross profit growth 5Y

6.65%

Net income growth

5.84%

Net income growth (Q)

-0.85%

Net income growth (QoQ)

-13.45%

Net income growth 3Y

3.3%

Net income growth 5Y

4.89%

Net income growth years

OCF growth

-13.21%

OCF growth (Q)

3.52%

OCF growth (QoQ)

274.87%

OCF growth 10Y

3.22%

OCF growth 3Y

29.8%

OCF growth 5Y

-1.51%

Operating income growth

8.77%

Operating income growth (Q)

9.68%

Operating income growth 3Y

3.34%

Operating income growth 5Y

4.46%

Revenue growth

13.02%

Revenue growth (Q)

18.2%

Revenue growth (QoQ)

1.26%

Revenue growth 10Y

7.26%

Revenue growth 3Y

7.65%

Revenue growth 5Y

9.58%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

IDR -830.9B

Depreciation and amortization

IDR 426.3B

EBIT

IDR 4.6T

EBITDA

IDR 5T

EPS

IDR 79.56

FCF per share

IDR 52.89

Financing cash flow

IDR -1.2T

Free cash flow

IDR 2.4T

Gross profit

IDR 14.1T

Income taxes

IDR 1T

Investing cash flow

IDR -1.1T

Net borrowing

IDR 6.4B

Net cash flow

IDR 1T

Net income

IDR 3.6T

Operating income

IDR 4.6T

Revenue

IDR 37.7T

Metric

Value

Altman Z-Score

7.45

Book value per share

IDR 537.67

Debt / EBITDA

0.16

Debt / equity

0.03

Debt / FCF

0.35

Goodwill

IDR 626.8B

Interest coverage

171.99

Long-term assets

IDR 12.1T

Long-term liabilities

IDR 659.5B

Net cash (debt)

IDR 4.2T

Net cash / market cap

12.5%

Net cash growth

31.22%

Net debt / EBITDA

-0.82

Net debt / equity

-0.16

Net debt / FCF

-1.74

Piotroski F-Score

Property, plant and equipment

IDR 8.4T

Shareholders' equity

IDR 25.8T

Tangible book value

IDR 22.1T

Tangible book value per share

IDR 487.34

Total assets

IDR 33.1T

Total cash

IDR 5T

Total debt

IDR 826.5B

Total liabilities

IDR 7.3T

WACC

3.97%

Metric

Value

Asset turnover

1.21

Current assets

IDR 21T

Current liabilities

IDR 6.7T

Current ratio

3.15

Inventory turnover

3.17

Net working capital

IDR 10T

Quick ratio

1.78

Working capital

IDR 14.3T

Working capital turnover

2.77

Metric

Value

Buyback yield / dilution

0.91%

Dividend growth

-44.44%

Dividend growth (10Y)

0.51%

Dividend growth (3Y)

-19.26%

Dividend growth (5Y)

-10.07%

Dividend growth years

Dividend payment date

2026-06-24

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

IDR 20.00

Dividend yield

2.72%

Ex-dividend date

2026-06-04

FCF payout ratio

37.82%

Last dividend

IDR 20.00

Payout ratio

25.07%

Shareholder yield

3.63%

Metric

Value

10Y price change

-57.88%

10Y return CAGR

-6.41%

10Y total return

-48.46%

150-day SMA

IDR 798.97

15Y price change

5.76%

15Y return CAGR

2.24%

15Y total return

39.4%

1D price change

3.52%

1W price change

5.76%

1W total return

5.76%

1Y price change

-42.35%

1Y return CAGR

-40.75%

1Y total return

-40.73%

20-day SMA

IDR 735.50

200-day SMA

IDR 882.25

20Y price change

176.32%

20Y return CAGR

7.01%

20Y total return

287.66%

3M price change

2.8%

3M total return

2.8%

3Y price change

-58.12%

3Y return CAGR

-23.37%

3Y total return

-55.02%

50-day SMA

IDR 754.50

50-day SMA vs 200-day SMA

50under200

52-week high

IDR 1,345.00

52-week high date

2025-10-28

52-week low

IDR 630.00

52-week low date

2026-10-19

5Y price change

-54.06%

5Y return CAGR

-12.48%

5Y total return

-48.66%

6M price change

-16%

6M total return

-13.63%

All-time high

IDR 2,360.00

All-time high date

2023-02-10

All-time low

IDR 2.13

All-time low date

1998-09-21

Average true range (ATR)

IDR 30.77

Average volume

56.8M

Beta (1Y)

0.21

Beta (2Y)

0.45

Beta (5Y)

-0.05

Change from 52-week high

-45.35%

Change from 52-week low

16.67%

Change from all-time high

-68.86%

Change from all-time low

34,439.47%

Change from open

2.8%

Day's gap

0.7%

Dollar volume

IDR 38.8B

High price

IDR 740.00

Low price

IDR 715.00

Monthly RSI

29.85

Open price

IDR 715.00

Position in 52-week range

80%

Previous close

IDR 710.00

Price vs 150-day SMA

-8.01%

Price vs 20-day SMA

-0.07%

Price vs 200-day SMA

-16.69%

Price vs 50-day SMA

-2.58%

Relative volume

0.94

RSI

50.03

Sharpe ratio

-0.74

Sharpe ratio (3Y)

-0.66

Sharpe ratio (5Y)

-0.19

Sortino ratio

-0.95

Sortino ratio (3Y)

-0.81

Sortino ratio (5Y)

-0.11

Volume

52.9M

Weekly RSI

42.98

YTD price change

-39%

YTD total return

-37.29%

Metric

Value

Float

18B

Shares change (QoQ)

Shares change (YoY)

-0.91%

Shares held by insiders

0.35%

Shares held by institutions

8.31%

Shares outstanding

45.2B

IDX/KLBF (IDX/KLBF)

Price

Financial snapshot

Fair-value bridge

Latest news · IDX/KLBF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IDX/KLBF indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IDX/KLBF

Frequently asked questions

IDX/KLBF (IDX/KLBF)

Price

Financial snapshot

Fair-value bridge

Latest news · IDX/KLBF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IDX/KLBF indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IDX/KLBF

Frequently asked questions